跳至主要内容
临床试验/DRKS00021577
DRKS00021577招募中不适用

Development of a screening tool for hATTR polyneuropathy (AmyloScan®)

niversitätsklinikum Schleswig-Holstein Campus Kiel0 个研究点目标入组 120 人开始时间: 2020年5月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Study participants have to suffer from one of the following disease entities:
  • - ATTRv amlyoidosis with polyneuropathy (documented mutation)
  • - polyneuropathy of other etiology
  • - pain caused by knee osteoarthritis
  • Study participants must have signed a consent form in which they declare that they understand the purpose of the study and the procedures used in it and that they consent to the study. Participants must be able to communicate adequately and be able to identify and differentiate the location and intensity of pain and complete the questionnaires used in this study.

排除标准

  • Exclusion criteria are pain syndromes of other causes, which could possibly compete with the pain, and severe psychiatric disorders, e.g. severe depression.

研究者

发起方
niversitätsklinikum Schleswig-Holstein Campus Kiel

相似试验

Development of a screening tool for hATTR... | 临床试验